Zimmermann Investment Management & Planning LLC Buys Shares of 4,142 Colgate-Palmolive (NYSE:CL)

Zimmermann Investment Management & Planning LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,142 shares of the company’s stock, valued at approximately $402,000.

A number of other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $731,843,000. Price T Rowe Associates Inc. MD increased its stake in Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after purchasing an additional 8,933,912 shares in the last quarter. Swedbank AB acquired a new position in Colgate-Palmolive during the 1st quarter valued at approximately $286,370,000. Magellan Asset Management Ltd lifted its stake in shares of Colgate-Palmolive by 4,162.6% during the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock worth $160,718,000 after buying an additional 1,968,988 shares during the period. Finally, Confluence Investment Management LLC purchased a new stake in shares of Colgate-Palmolive during the first quarter valued at $130,622,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 0.1 %

Shares of NYSE:CL traded down $0.13 during trading hours on Wednesday, reaching $105.79. The stock had a trading volume of 3,216,368 shares, compared to its average volume of 4,336,206. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $106.72. The firm’s 50 day moving average is $99.57 and its 200-day moving average is $93.27. The stock has a market capitalization of $86.79 billion, a price-to-earnings ratio of 33.48, a P/E/G ratio of 3.54 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. Research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.89%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Activity at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last ninety days. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the subject of a number of research reports. BNP Paribas initiated coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price target for the company. Stifel Nicolaus lifted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. Sanford C. Bernstein increased their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Colgate-Palmolive from $104.00 to $107.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.